Journal Article

Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial

Vikram Kumar, P. Ramesh, Rakesh Lodha, R. M. Pandey and S. K. Kabra

in Journal of Tropical Pediatrics

Volume 53, issue 5, pages 325-330
Published in print October 2007 | ISSN: 0142-6338
Published online October 2007 | e-ISSN: 1465-3664 | DOI: http://dx.doi.org/10.1093/tropej/fmm038
Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial

Show Summary Details

Preview

Background: Guidelines recommend daily controller therapy for mild persistent asthma. Montelukast has demonstrated consistent benefit in controlling symptoms of asthma and may be an alternative, orally administered, nonsteroidal agent for treating mild asthma.

Aim: To determine whether montelukast is as effective as budesonide in controlling mild persistent asthma as determined by FEV1.

Methods: Between November 2003 to October 2005, participants aged 5–15 years with recently diagnosed mild persistent asthma (n = 62) were randomized to oral montelukast (5 mg daily) [N1 = 30] or inhaled budesonide (400 μg per day in two doses) [N2 = 32] in a single center, double-blind study.

Results: Baseline demographic and spirometric parameters were comparable. The median (95% confidence interval) percentage predicted FEV1 was similar in the two groups after 12 weeks of treatment (budesonide: 76.70 (67.96–90.53%), montelukast: 75 (67.40–88.47)%; p = 0.44). There was similar improvement in spirometric parameters and clinical symptom scores in both the groups. There was no statistically significant difference between the groups in the need for rescue drugs as well as side effects reported by parents.

Conclusion: Montelukast is as effective as inhaled budesonide in the treatment of mild persistent asthma in children aged 5–15 years. Montelukast may be used as an alternative to low dose inhaled corticosteroids for management of mild persistent asthma.

Keywords: mild persistent asthma; montelukast; budesonide

Journal Article.  2538 words.  Illustrated.

Subjects: Paediatrics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.